This trial will study how brain activity affects OCD, and test new treatments to see if they help.
- Obsessive-Compulsive Disorder
1 Primary · 1 Secondary · Reporting Duration: pre-treatment up to 1-month post-treatment
Side Effects for
Awards & Highlights
2 Treatment Groups
Right Prefrontal Cortex (rPFC)
1 of 2
Medial Prefrontal Cortex (MPFC)
1 of 2
360 Total Participants · 2 Treatment Groups
Primary Treatment: Medial Prefrontal Cortex (MPFC) · No Placebo Group · N/A
Who is running the clinical trial?
Age 18 - 80 · All Participants · 10 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Are there any vacancies available in this trial for individuals seeking treatment?
"Affirmative. According to clinicaltrials.gov, this research project is in full recruitment mode as of April 24th 2023. Initially posted on March 14th 2022, it aims to enrol 360 participants from two distinct medical centres." - Anonymous Online Contributor
Am I eligible to join this research endeavor?
"This clinical trial seeks to enrol 360 participants, who must be between 18 and 80 years old with a diagnosis of obsessive-compulsive disorder." - Anonymous Online Contributor
How many participants are part of this clinical experiment?
"Yes, the trial is currently open for enrollment. As per information on clinicaltrials.gov, this study was first uploaded on March 14th of 2022 and most recently updated April 24th 2023. The research team seeks 360 participants across two distinct locations." - Anonymous Online Contributor
Is this investigation open to those aged 55 and above?
"This trial only enrols patients aged 18 to 80. Those younger than 18 can join one of the 22 trials available, while those older than 65 are able to choose from 69 medical studies." - Anonymous Online Contributor